Featured Videos |view more
Video
Tumor-Treating Fields for Glioblastoma and Other Brain Tumors
In this video, two MUSC Hollings Cancer Center neuro-oncologists, Scott M. Lindhorst, M.D., and David M. Cachia, M.D., discuss their experience with TTFields and the clinical trials they are leading in patients who have failed Avastin therapy.
Video
Resection of Pineocytomas Offers Symptom Relief
Sunil J. Patel, M.D., chair of the Department of Neurosurgery at MUSC, is one of a handful of surgeons in the world who resects symptomatic pineal cysts.
Video
Reanimating the Paralyzed Face
Samuel L. Oyer, M.D., discusses a technique used in facial reanimation surgery — masseter-to-facial nerve transfer — that can restore a patient’s ability to smile.
Video
Laser Ablation for Controlling Seizures in Temporal Lobe Epilepsy
William A. Vandergrift, M.D., discusses, Laser ablation, in which a laser is inserted through a screw fitted in a very small hole in the skull and guided to the appropriate area of the brain, which offers a minimally invasive alternative for epilepsy.
Video
Edward C. Jauch, M.D., interim chair of the Department of Emergency Medicine at the Medical University of South Carolina, discusses what’s new in this update regarding thrombolytic therapy, endovascular surgery, in-hospital care, credentialing and more.
Video
Preliminary Results of a Head-to-Head Trial of Stent Retrievers vs. the Direct-Aspiration, First-Pass Technique (ADAPT)
Video
Improving Quality of Life for Patients with Movement Disorders Through Deep Brain Stimulation
MUSC Health neurosurgeon Istvan Takacs, M.D., describes how deep brain stimulation (DBS) works, the advantages of performing it awake and how it can dramatically affect the quality of life of patients with movement disorders such as Parkinson’s disease.
Video
New Techniques for Treating Secondary Effects of Intracerebral Hemorrhage Stroke
In this video, MUSC Health neurosurgeon Alejandro M. Spiotta, M.D. discusses three minimally invasive surgical (MIS) techniques for evacuation of hematoma in patients who experience intracerebral hemorrhage (ICH)
Video
Carotid Stenosis and CREST-2 Trial
Marc I. Chimowitz, MBChB, professor of neurology, Countess Alicia Paolozzi SmartStateTM Endowed Chair and associate dean of faculty development at the Medical University of South Carolina, discusses carotid stenosis and the CREST-2 trial.
Featured Documents |view more
Document
A Rare Case of Bobblehead Syndrome
Sunil Patel, MD, in his 30 year career as a neurosurgeon, had never seen a case of the rarely diagnosed Bobble head Doll Syndome, until he met Mickey, a typical two year-old toddler.
Document
A Pioneering New Technique for Mechanical Thrombectomy
In 2015, five landmark clinical trials provided the evidence that mechanical thrombectomy using stent retrievers was safe and effective for certain patients with acute ischemic stroke.
Document
An Innovative Collaboration to Improve Stroke Care
Two competing hospitals will pool resources to use telestroke and other innovative approaches to reduce barriers to stroke care and improve quality.
Document
Conversing with the Brain: Responsive Neurostimulation Helps Prevent Partial Epileptic Seizures
Therapies for a variety of conditions, ranging from Parkinson’s disease to depression, have been developed that intervene in that communication by sending a electrical charge via an implanted microprocessor.
Document
Damping Injury after Stroke: Innate Immune System Navigation can be Hacked for Stroke Protection
Stroke patients are faced with danger on two fronts. First, when a clot blocks blood flow, brain tissue is starved of oxygen and begins to die.
Document
Predicting Language Deficits after Stroke with Connectome-Based Imaging
Loss or impairment of the ability to speak is one of the most feared complications of stroke- one faced by about 20% of stroke patients.
MUSC Health Neurosciences ranks first in the Southeast and second in the country in National Institutes of Health neuroscience research funding. It places researchers and clinicians at each other’s side in an effort to realize the clinical promise of cutting-edge research. As a consistent leader in neuroscience advances, MUSC Health is:
